Selank is a synthetic heptapeptide developed as a research compound, and the sourcing and quality problems attached to it trace to the market it moves through rather than to the molecule itself. Almost all Selank offered for sale carries a research-use-only designation, which places it outside the pharmaceutical supply chain and the manufacturing controls that govern anything intended for human use. What a given vial actually contains becomes a question of who made the material, under what controls, and how it was handled afterward.
Because research-use-only Selank sits outside enforced good manufacturing practice, its purity, identity, and contamination status all trace to its source, and independent laboratory testing by mass spectrometry and high-performance liquid chromatography is the only reliable confirmation of what a vial contains.
Research-market Selank usually sits several steps removed from the vendor a buyer interacts with. The compound is produced by solid-phase peptide synthesis at chemical manufacturers, often in bulk, then passed to distributors and resellers who divide it, vial it, and apply their own labels. A research-use-only designation is not a mark of purity; it is a commercial classification signaling the material was never validated for human administration.
A research-use-only classification certifies only that Selank was not made to pharmaceutical standards, so two vendors selling the same named compound may be drawing from entirely different synthesis sources with different purification rigor.
Impurity in a research-grade peptide is rarely one problem; it is a family of them, each traceable to a step in synthesis or purification. A single purity number can mislead, because a chromatographic percentage reports only how much of the sample is the main peak by that separation, not the peptide's identity, its content by mass, or contaminants the method was never designed to see.
A chromatographic purity percentage confirms only the size of the main peak by one separation method, so it can read high while the vial still holds sequence-related impurities and process residues the assay never measured.
Mislabeling is one of the better-documented failures in the research-peptide market, and third-party analyses have repeatedly found gaps between labeled and actual content. It takes more forms than most buyers expect, and the pattern is consistent enough that no single vial can be assumed accurate on the strength of its label alone.
When a vial's stated amount is overstated at the label, that same error propagates through every reconstitution calculation, so a quantity mismatch is wrong once on the vial and wrong again at every later concentration derived from it.
A certificate of analysis reports the results of specific tests run on a specific production batch, commonly a chromatographic purity figure, a mass spectrometry result confirming molecular weight, and sometimes water content. Read as supporting evidence it is useful; treated as proof it fails on three points, which is precisely where independent third-party testing differs.
| Criteria | Vendor certificate | Independent testing |
|---|---|---|
| Scope | Reports only the tests run; often silent on endotoxin, microbial load, and net peptide content | Can be scoped to cover the contaminants a vendor certificate omits |
| Subject | Characterizes the batch at manufacture, not the individual vial in hand | Performed on the buyer's own vial as received |
| Authenticity | A file that can be copied, edited, or fabricated wholesale | Run by a laboratory the buyer selects, not the seller |
A certificate of analysis describes a batch at the time of manufacture rather than the individual vial a buyer holds, so even a genuine certificate cannot confirm the identity, purity, or contamination status of the material actually received.
The absence of regulatory oversight is the root condition that makes every other sourcing problem possible, because regulation is what normally forces the controls a buyer otherwise has to hope for. In a regulated setting, good manufacturing practice mandates validated processes, documented batch records, defined purity and contaminant limits, and independent inspection; a research-use-only product sits outside that framework by design.
Because a research-use-only product falls outside enforced good manufacturing practice, its purity figures, contamination status, and even its identity rest on the seller's own word and the seller's own testing, with no external party obligated to verify any of them.
Endotoxin and microbial contamination are a category of risk separate from chemical impurity, and they matter most because these products are formatted as powders meant for reconstitution into solution. A key distinction drives the whole problem: a preparation can be free of living organisms yet still carry the endotoxin left behind by bacteria that were present earlier and later killed or filtered out.
| Criteria | Sterility | Bacterial endotoxin |
|---|---|---|
| What it detects | Presence of viable microorganisms | Lipopolysaccharide fragments from dead gram-negative bacteria |
| Heat behavior | Organisms killed by heat | Heat-stable; survives processes that kill the bacteria |
| Test method | Sterility and bioburden testing | Limulus amebocyte lysate or recombinant factor C assay |
Bacterial endotoxin is heat-stable and survives both the death of the bacteria and the freeze-drying that produces the finished powder, so a dry product can be sterile and still carry endotoxin, a blind spot a standard certificate of analysis usually leaves untested.
Stability is the quality issue that persists after every sourcing question has been answered, because a peptide's condition at the moment of use depends on everything that happened to it between manufacture and that moment. Peptides degrade through predictable routes, including hydrolysis of the peptide bonds, oxidation, and aggregation, and the rate of all of these rises with temperature and with time spent in solution.
A peptide that left synthesis clean can still arrive degraded, because purity at manufacture is necessary but not sufficient when a product crosses a supply chain without temperature control or sits in transit heat before it is ever opened.
Confirming what a peptide actually is and how pure it is requires complementary methods, because no single technique answers both questions at once. Mass spectrometry and high-performance liquid chromatography address different halves of the problem, and identity and purity are only jointly established when both are used, ideally coupled as liquid chromatography with mass spectrometry detection.
| Criteria | Mass spectrometry | High-performance liquid chromatography |
|---|---|---|
| What it establishes | Identity, by measuring molecular mass with high precision | Purity, by separating components and quantifying the main peak |
| What it flags | Mass shifts from deletion sequences, oxidation, or the wrong compound | The proportion of impurity peaks against the target |
| Blind spot | Does not quantify how much of the sample is something else | A clean single peak does not prove that peak is the right molecule |
Mass spectrometry confirms identity and high-performance liquid chromatography confirms purity, but only an accredited independent laboratory analyzing the buyer's own vial removes the vendor's incentive and opportunity to report a favorable in-house result.
Educational use only. This article describes what the published scientific and clinical literature reports about Selank. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
